Trial · NCT03182244
Participant flow26
How many started, completed or left each group, period by period.
1 to 20 of 26
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (Upto 1917 Days) | STARTED | Gilteritinib | 137 | |
| Treatment Period (Upto 1917 Days) | STARTED | Salvage Chemotherapy | 139 | |
| Treatment Period (Upto 1917 Days) | LoDAC | Gilteritinib | 0 | |
| Treatment Period (Upto 1917 Days) | LoDAC | Salvage Chemotherapy | 27 | |
| Treatment Period (Upto 1917 Days) | MEC | Gilteritinib | 0 | |
| Treatment Period (Upto 1917 Days) | MEC | Salvage Chemotherapy | 42 | |
| Treatment Period (Upto 1917 Days) | FLAG | Gilteritinib | 0 | |
| Treatment Period (Upto 1917 Days) | FLAG | Salvage Chemotherapy | 70 | |
| Treatment Period (Upto 1917 Days) | Chinese PK Cohort | Gilteritinib | 21 | |
| Treatment Period (Upto 1917 Days) | Chinese PK Cohort | Salvage Chemotherapy | 0 | |
| Treatment Period (Upto 1917 Days) | COMPLETED | Gilteritinib | 0 | |
| Treatment Period (Upto 1917 Days) | COMPLETED | Salvage Chemotherapy | 26 | |
| Treatment Period (Upto 1917 Days) | NOT COMPLETED | Gilteritinib | 137 | |
| Treatment Period (Upto 1917 Days) | NOT COMPLETED | Salvage Chemotherapy | 113 | |
| Long Term Follow-up (Up to 1232 Days) | STARTED | Gilteritinib | 100 | |
| Long Term Follow-up (Up to 1232 Days) | STARTED | Salvage Chemotherapy | 105 | |
| Long Term Follow-up (Up to 1232 Days) | COMPLETED | Gilteritinib | 9 | |
| Long Term Follow-up (Up to 1232 Days) | COMPLETED | Salvage Chemotherapy | 12 | |
| Long Term Follow-up (Up to 1232 Days) | NOT COMPLETED | Gilteritinib | 91 | |
| Long Term Follow-up (Up to 1232 Days) | NOT COMPLETED | Salvage Chemotherapy | 93 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03182244/flow